Xudong He

Florida International University, Miami, FL, United States 
Computer Science
"Xudong He"
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

He X, Cao Y, Gu Y, et al. (2021) ASO Author Reflections: Optimization of Tumor Therapy for the Specific Immune Microenvironment of Gastric Cancer. Annals of Surgical Oncology
He X, Cao Y, Gu Y, et al. (2021) Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients. Annals of Surgical Oncology
He X, Zhang D, Zhang L, et al. (2021) Neurological and psychiatric presentations associated with COVID-19. European Archives of Psychiatry and Clinical Neuroscience
Shi M, Gu Y, Jin K, et al. (2021) CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration. Cancer Immunology, Immunotherapy : Cii
Chen F, He X, Fang B, et al. (2020) Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use. Drug Design, Development and Therapy. 14: 5689-5698
Gu Y, Chen Y, Jin K, et al. (2020) Intratumoral CD103CD4 T cell infiltration defines immunoevasive contexture and poor clinical outcomes in gastric cancer patients. Oncoimmunology. 9: 1844402
Cheng H, Xu C, Jin X, et al. (2020) Association of Blood Pressure at Successful Recanalization and Parenchymal Hemorrhage After Mechanical Thrombectomy With General Anesthesia. Frontiers in Neurology. 11: 582639
Liu X, Cao Y, Lv K, et al. (2020) Tumor-infiltrating podoplanin cells in gastric cancer: clinical outcomes and association with immune contexture. Oncoimmunology. 9: 1845038
Lv K, Li R, Cao Y, et al. (2020) LAG-3 expression associates with poor prognosis and immunoevasive contexture in EBV-positive and MLH1-defective gastric cancer patients. International Journal of Cancer
Wu Q, Chu Q, Zhang H, et al. (2020) Clinical outcomes of coronavirus disease 2019 (COVID-19) in cancer patients with prior exposure to immune checkpoint inhibitors. Cancer Communications (London, England)
See more...